Trial intelligence / Profile preview

Continuous parietal ropivacaine infiltration and diaphragmatic function after upper abdominal surgery

2013-002184-26Phase 4Active

Sponsor
Rouen University Hospital
Start
Sep 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in Diaphragmatic dysfunction (DD), sponsored by Rouen University Hospital. Primary endpoint: Diaphragmatic function (sniff test). Started Sep 2015; status: active.

02

Drugs

ropivacaine
03

Conditions

Diaphragmatic dysfunction (DD)

Beyond the preview

Go deeper on 2013-002184-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002184-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call